These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers]. Tsukayama S, Hirano M, Murakami N, Uno Y, Nozawa H, Yoshino H, Orta N, Kikkawa H, Masuda S. Gan To Kagaku Ryoho; 2001 May; 28(5):649-54. PubMed ID: 11383213 [Abstract] [Full Text] [Related]
4. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer]. Tamesa M, Yamamoto S, Maeda N, Nagashima Y, Oka M. Gan To Kagaku Ryoho; 2008 Mar; 35(3):431-6. PubMed ID: 18347391 [Abstract] [Full Text] [Related]
5. Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. Hiroyasu S, Shiraishi M, Samura H, Tokashiki H, Shimoji H, Isa T, Muto Y. Jpn J Clin Oncol; 2001 Feb; 31(2):65-8. PubMed ID: 11302344 [Abstract] [Full Text] [Related]
6. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C. Oncology; 2006 Feb; 70(5):366-77. PubMed ID: 17179731 [Abstract] [Full Text] [Related]
7. [Significance of tissue PyNPase, TS, and DPD activities in breast cancer]. Kosaka A, Mori K, Shikata A. Gan To Kagaku Ryoho; 2002 Aug; 29(8):1395-401. PubMed ID: 12214467 [Abstract] [Full Text] [Related]
8. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer. Oi K, Makino M, Ozaki M, Takemoto H, Yamane N, Nakamura S, Ikeguchi M, Kaibara N. Anticancer Res; 2004 Aug; 24(1):273-9. PubMed ID: 15015608 [Abstract] [Full Text] [Related]
9. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Tokunaga Y, Takahashi K, Saito T. Hepatogastroenterology; 2005 Aug; 52(66):1715-21. PubMed ID: 16334763 [Abstract] [Full Text] [Related]
10. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer]. Seo S, Miki A, Iwaisako K, Kamo N, Inomoto T, Kitai T, Ukikusa M. Gan To Kagaku Ryoho; 2006 Nov; 33(11):1579-82. PubMed ID: 17108722 [Abstract] [Full Text] [Related]
11. High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. Noguchi T, Moriyama H, Wada S, Takeno S, Kimura Y, Uchida Y, Gabbert HE. Dis Esophagus; 2003 Nov; 16(4):307-11. PubMed ID: 14641294 [Abstract] [Full Text] [Related]
12. Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer. Nakayama Y, Inoue Y, Nagashima N, Katsuki T, Matsumoto K, Kadowaki K, Shibao K, Tsurudome Y, Hirata K, Sako T, Nagata N, Itoh H. Anticancer Res; 2005 Nov; 25(6A):3755-61. PubMed ID: 16302736 [Abstract] [Full Text] [Related]
13. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer]. Honda M, Tanaka Y, Matsuo Y, Yamamoto S, Hazama K, Inoue Y, Takao T, Fushimi H. Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321 [Abstract] [Full Text] [Related]
14. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase) and clinicopathological factors in patients with gastric cancer]. Onoyama H, Urakawa T, Azumi Y, Hashimoto Y, Sugihara S, Saitoh Y. Gan To Kagaku Ryoho; 2000 Jul; 27(7):1015-20. PubMed ID: 10925687 [Abstract] [Full Text] [Related]
15. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Watanabe T, Ochiai M, Tanimura H, Tsubota YT. Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545 [Abstract] [Full Text] [Related]
16. [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients]. Akao S, Inoue K. Gan To Kagaku Ryoho; 2003 Sep; 30(9):1361-4. PubMed ID: 14518422 [Abstract] [Full Text] [Related]
17. Tumor dihydropyrimidine dehydrogenase expression is a useful marker in adjuvant therapy with oral fluoropyrimidines after curative resection of colorectal cancer. Tsuji T, Sawai T, Takeshita H, Nakagoe T, Hidaka S, Yamaguchi H, Yasutake T, Nagayasu T, Tagawa Y. Cancer Chemother Pharmacol; 2004 Dec; 54(6):531-6. PubMed ID: 15309506 [Abstract] [Full Text] [Related]
18. Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy. Nishimura G, Terada I, Kobayashi T, Ninomiya I, Kitagawa H, Fushida S, Fujimura T, Kayahara M, Shimizu K, Ohta T, Miwa K. Oncol Rep; 2002 Dec; 9(3):479-82. PubMed ID: 11956613 [Abstract] [Full Text] [Related]
19. [Prognosis and efficacy of postoperative adjuvant chemotherapy in colorectal cancer correlates with nucleic acid metabolizing enzymes]. Katsumata K, Sumi T, Wada T, Katou K, Aoki T. Gan To Kagaku Ryoho; 2004 Sep; 31(9):1357-60. PubMed ID: 15446556 [Abstract] [Full Text] [Related]
20. The relationship between survival and the expression of dihydropyrimidine dehydrogenase in patients with colorectal cancer. Hotta T, Takifuji K, Taniguchi K, Sahara M, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, Oku Y, Yamaue H. Oncol Rep; 2006 Jul; 16(1):177-82. PubMed ID: 16786143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]